Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T2OT
|
|||
| Former ID |
DIB002144
|
|||
| Drug Name |
GW-278884
|
|||
| Synonyms |
BW-668W95; 668W95
Click to Show/Hide
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Terminated | [1] | |
| Company |
Glaxo Wellcome plc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Enzyme unspecific (Enz) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011272) | |||
| REF 2 | WO patent application no. 2010,1112,71, Orally bioavailable lipid-based constructs. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.